Carolina de Aguiar Ferreira couldn’t do what she does anywhere else.
The assistant professor has the resources at Michigan State University to precisely target cancer cells with diagnostics and therapies using radioisotopes produced by what is designed to be the world's most powerful heavy-ion accelerator.
When considering where to pursue her career, she knew MSU provided the perfect environment.
Henry Ford Health + Michigan State University Health Sciences has announced its integration grant recipients for the 2023 Cancer Seed Funding Program. This year’s program funded four cancer research grants of up to $75,000 each. These four grants follow the funding of 20 pilot grants of $25,000 each in July 2023.
On November 9 and 10, over 225 Henry Ford Health + Michigan State University Health Sciences researchers gathered on the MSU campus for the 3rd Annual Henry Ford + MSU Cancer Research Symposium.
The two-day event focused on advancing research through innovation and collaboration. With more than 30 research presentations from Henry Ford and MSU, topics ranged from experimental and clinical therapeutics to opportunities for clinical trials and interventional studies.
For cancer survivors, taking oral medication may be more convenient than spending hours undergoing infusions, but it could come with trade-offs, according to a Michigan State University researcher and her colleagues.
Alla Sikorskii, a professor in the MSU College of Osteopathic Medicine’s Department of Psychiatry. By taking these oral medications, survivors may see their oncology teams less often, requiring them to deal with symptoms like fatigue, depression or skin rashes on their own. Unmanaged symptoms can result in cancer treatment interruptions or even lead to emergency room visits, said Alla Sikorskii, a professor in the MSU College of Osteopathic Medicine’s Department of Psychiatry.